Diversity of VanA glycopeptide resistance elements in enterococci from humans and nonhuman sources

被引:146
作者
Woodford, N
Adebiyi, AMA
Palepou, MFI
Cookson, BD
机构
[1] Cent Publ Hlth Lab, Antibiot Reference Unit, London NW9 5HT, England
[2] Cent Publ Hlth Lab, Lab Hosp Infect, London NW9 5HT, England
关键词
D O I
10.1128/AAC.42.3.502
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Elements mediating VanA glycopeptide resistance in 106 diverse enterococci from humans and nonhuman sources were compared with the prototype VanA transposon, Tn1546, in Enterococcus faecium BM4147. The isolates included 64 from individual patients at 15 hospitals in the United Kingdom (isolated between 1987 and 1996) and 42 from nonhuman sources in the United Kingdom (27 from raw meat, 7 from animal feces, and 8 from sewage). VanA elements were assigned to 24 groups (designated groups A to X) with primers that amplified 10 overlapping fragments of Tn1546. Ten groups of elements were found only in human enterococci, eight groups of elements were unique to nonhuman strains, and six groups of elements were common in enterococci from all sources. Elements indistinguishable from Tn1546 (group A) were observed more frequently in enterococci from nonhuman sources (34 versus 9%) but were identified in enterococci that caused outbreaks in hospital patients between 1987 and 1995. The most common group found in human enterococci (group H; 33%) was rarely observed in enterococci from other sources (5%). Group H elements differed from Tn1546 in three regions and included a novel insertion sequence, designated IS1542, between orf2 and vanR. The VanA elements of 14 other groups had a similar insertion at this position and/or distinct insertions at other positions. We conclude that VanA elements in enterococci are heterogeneous, although all show regions of homology with Tn1546. Furthermore, the elements most common among the human and nonhuman enterococci studied were different. This approach may be useful for monitoring the evolution of VanA resistance and may also be applicable in local "snapshot" epidemiological studies. However, as transposition events involving insertion sequences accounted for the differences observed between several groups, the stability of the elements must be assessed before their true epidemiological significance can be determined.
引用
收藏
页码:502 / 508
页数:7
相关论文
共 32 条
[1]   Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms [J].
Aarestrup, FM .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1995, 1 (03) :255-257
[2]   Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the vanA cluster [J].
Aarestrup, FM ;
Ahrens, P ;
Madsen, M ;
Pallesen, LV ;
Poulsen, RL ;
Westh, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (08) :1938-1940
[3]   The VanS sensor negatively controls VanR-mediated transcriptional activation of glycopeptide resistance genes of Tn1546 and related elements in the absence of induction [J].
Arthur, M ;
Depardieu, F ;
Gerbaud, G ;
Galimand, M ;
Leclercq, R ;
Courvalin, P .
JOURNAL OF BACTERIOLOGY, 1997, 179 (01) :97-106
[4]   CHARACTERIZATION OF TN1546, A TN3-RELATED TRANSPOSON CONFERRING GLYCOPEPTIDE RESISTANCE BY SYNTHESIS OF DEPSIPEPTIDE PEPTIDOGLYCAN PRECURSORS IN ENTEROCOCCUS-FAECIUM BM4147 [J].
ARTHUR, M ;
MOLINAS, C ;
DEPARDIEU, F ;
COURVALIN, P .
JOURNAL OF BACTERIOLOGY, 1993, 175 (01) :117-127
[5]   FARM-ANIMALS AS A PUTATIVE RESERVOIR FOR VANCOMYCIN-RESISTANT ENTEROCOCCAL INFECTION IN MAN [J].
BATES, J ;
JORDENS, JZ ;
GRIFFITHS, DT .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (04) :507-514
[6]   Genotypic characterization of a nosocomial outbreak of VanA Enterococcus faecalis [J].
Biavasco, F ;
Miele, A ;
Vignaroli, C ;
Manso, E ;
Lupidi, R ;
Varaldo, PE .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1996, 2 (02) :231-237
[7]   NUCLEOTIDE-SEQUENCE ANALYSIS OF IS256 FROM THE STAPHYLOCOCCUS-AUREUS GENTAMICIN-TOBRAMYCIN-KANAMYCIN-RESISTANCE TRANSPOSON TN4001 [J].
BYRNE, ME ;
ROUCH, DA ;
SKURRAY, RA .
GENE, 1989, 81 (02) :361-367
[8]  
CASEWELL M, 1996, J MED MICROBIOL, V44, pR5
[9]  
Chadwick PR, 1996, J ANTIMICROB CHEMOTH, V38, P908
[10]   Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States [J].
Coque, TM ;
Tomayko, JF ;
Ricke, SC ;
Okhyusen, PC ;
Murray, BE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (11) :2605-2609